VEGFA and Hyphema: Preoperative administration of anti-VEGF agents has been shown to induce rapid regression of fragile new vessels in the iris and the anterior chamber angle, thus effectively reducing the occurrence of intraoperative hyphema and increasing surgical success after AGV implantation.